Back
DarioHealth 10K Form
Sell
32
DRIO
DarioHealth
Last Price:
$0.69
Seasonality Move:
-1.23%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2023-11-02 | 10Q | DRIO/DarioHealth Quarterly |
2023-08-10 | 10Q | DRIO/DarioHealth Quarterly |
2023-05-11 | 10Q | DRIO/DarioHealth Quarterly |
2022-11-14 | 10Q | DRIO/DarioHealth Quarterly |
2022-08-15 | 10Q | DRIO/DarioHealth Quarterly |
2022-05-12 | 10Q | DRIO/DarioHealth Quarterly |
Receive DRIO News And Ratings
See the #1 stock for the next 7 days that we like better than DRIO
DRIO Financial Statistics
Sales & Book Value
Annual Sales: | $27M |
---|---|
Cash Flow: | $-6.8M |
Price / Cash Flow: | 0 |
Annual Sales: | $1.88 |
Price / Book: | 0.4 |
Profitability
EPS (TTM): | -0.84940 |
---|---|
Net Income (TTM): | $-42.7M |
Gross Margin: | $13.3M |
Return on Equity: | -63.85% |
Return on Assets: | -36.58% |
DarioHealth Earnings Forecast
Key DarioHealth Financial Ratios
-
The Gross Profit Margin over the past 12 years for DRIO is 49.06%.
-
The Selling, General & Administrative Expenses for DRIO have been equal to 173.20% of Gross Profit Margin.
-
The Research & Development expenses have been 89.42% of Revenue.
-
The Net Earning history of DRIO is -158.09% of Total Revenues.
-
Per Share Earnings over the last 13 years have been positive in 10 years.
DarioHealth Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Health Care Technology |
Sector: | Health Care |
Current Symbol: | DRIO |
CUSIP: | 23725P |
Website: | mydario.com |
Debt
Debt-to-Equity Ratio: | 0.4 |
---|---|
Current Ratio: | 2.44 |
Quick Ratio: | 2.03 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 0 |
DRIO Technical Analysis vs Fundamental Analysis
Sell
32
DarioHealth (DRIO)
is a Sell
Is DarioHealth a Buy or a Sell?
-
DarioHealth stock is rated a SellThe current DarioHealth [DRIO] share price is $0.69. The Score for DRIO is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.